BioSpace News Archive

Business

Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease

Lumen Bioscience announced today it has entered into a research collaboration with Novo Nordisk to evaluate the use of Lumen’s unique drug development and manufacturing platform in Novo Nordisk’s research and development activities within obesity and other metabolic disorders.

June 16, 2021
·
2 min read
Pharm Country

National Kidney Foundation Connecting Kidney Patients, Care Partners, Investigators for Better Research

The National Kidney Foundation unveiled a new portal to connect kidney patients, care partners, and living donors with researchers where they can partner on patient-centered outcomes research.

June 16, 2021
·
3 min read
Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures

Ochre Bio today announced the closing of a $9.6M seed financing round led by Khosla Ventures, with participation from Backed VC, Apollo Health Ventures, Selvedge, Hoxton and Hermes-Epitek.

June 16, 2021
·
3 min read
Policy

Kytopen Awarded NIH Grant of Up to $2M to Unlock the Power of Engineered Natural Killer (NK) Cells via Flowfect® Platform

NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral delivery platform that alleviates current limitations on NK cell gene editing

June 16, 2021
·
5 min read
Genetown

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine

Moderna, Inc., (Nasdaq: MRNA) today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.

June 16, 2021
·
8 min read
Deals

Brain Scientific Enters into Merger Agreement with Piezo Motion Closing Contemplates Minimum $5 Million Capital Investment For Combined Company

Brain Scientific Inc. announces today that it has entered into a definitive merger agreement to acquire Piezo Motion Corp.

June 16, 2021
·
6 min read
Business

Crinetics Pharmaceuticals Appoints Garlan Adams as General Counsel

Crinetics Pharmaceuticals, Inc. today announced the appointment of Garlan Adams to the newly created role of general counsel.

June 16, 2021
·
3 min read
Drug Development

Gannex Announces Positive Topline Results of the U.S. Phase I Trial of NASH Drug ASC42, an FXR Agonist

Gannex today announces positive topline results of safety and pharmacodynamic biomarkers from the U.S. Phase I trial of NASH drug farnesoid X receptor (FXR) agonist ASC42.

June 16, 2021
·
4 min read
Campbell Neurosciences Spin Off of Therapeutic Solutions Reports Synergistic Reduction of Schizophrenia in Animal Models using Low Dose Naltrexone and T Regulatory Cell Stimulation

Suicide Prevention Company Continues Experimental Validation of its >1000 Claim Patent on Application of Immunotherapy to Schizophrenia

June 16, 2021
·
2 min read
BioMidwest

Swift Biosciences Meets NGS Demands by Offering 1536-Plex UDIs

Swift Biosciences, pioneers in the development of library preparation and targeted sequencing solutions for next generation sequencing (NGS) in research applications, has announced the availability of expanded Swift Normalase Unique Dual Indexing Plates up to 1536-plex.

June 16, 2021
·
2 min read